Laura Ghilardi - Publications

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 28, 2022

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 27, 2020

Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.

Journal: The oncologist

Published: July 03, 2020

A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 26, 2020

Nivolumab efficacy in leptomeningeal metastasis of renal cell carcinoma: a case report.

Journal: Tumori

Published: February 12, 2020

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 09, 2019

CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 26, 2018

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.

Journal: Journal of the American Academy of Dermatology

Published: March 23, 2018